BR112013020841B8 - Processo para preparar produtos que compreendem ativos estabilizados e composições que compreendem os mesmos - Google Patents
Processo para preparar produtos que compreendem ativos estabilizados e composições que compreendem os mesmosInfo
- Publication number
- BR112013020841B8 BR112013020841B8 BR112013020841A BR112013020841A BR112013020841B8 BR 112013020841 B8 BR112013020841 B8 BR 112013020841B8 BR 112013020841 A BR112013020841 A BR 112013020841A BR 112013020841 A BR112013020841 A BR 112013020841A BR 112013020841 B8 BR112013020841 B8 BR 112013020841B8
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- same
- preparing products
- actives
- stabilized
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000012620 biological material Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
- B01J13/043—Drying and spraying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/02—Processes for applying liquids or other fluent materials performed by spraying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
processo para preparar produtos que compreendem ativos estabilizados e composições que compreendem os mesmos. trata-se, de modo geral, de um processo para preparar produtos que compreendem componentes ativos e, em particular, de materiais biológicos, em que os componentes ativos são estabelecidos. trata-se, ainda, de composições que compreendem os produtos e, em particular, a composições que compreendem materiais biológicos terapêuticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/AU2011/000173 WO2012109694A1 (en) | 2011-02-18 | 2011-02-18 | Process for preparing products comprising stabilised actives and compositions comprising same |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112013020841A2 BR112013020841A2 (pt) | 2016-08-02 |
BR112013020841B1 BR112013020841B1 (pt) | 2021-10-26 |
BR112013020841B8 true BR112013020841B8 (pt) | 2021-11-30 |
Family
ID=46671860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013020841A BR112013020841B8 (pt) | 2011-02-18 | 2011-02-18 | Processo para preparar produtos que compreendem ativos estabilizados e composições que compreendem os mesmos |
Country Status (13)
Country | Link |
---|---|
US (2) | US8951566B2 (pt) |
EP (2) | EP2675301B1 (pt) |
JP (1) | JP5793578B2 (pt) |
KR (1) | KR101796340B1 (pt) |
CN (1) | CN102791151B (pt) |
AU (1) | AU2011323059B2 (pt) |
BR (1) | BR112013020841B8 (pt) |
CA (1) | CA2827432C (pt) |
DK (1) | DK2675301T3 (pt) |
ES (1) | ES2832973T3 (pt) |
MX (2) | MX359670B (pt) |
RU (1) | RU2563685C2 (pt) |
WO (1) | WO2012109694A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2563685C2 (ru) * | 2011-02-18 | 2015-09-20 | Сай Ин КО | Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые |
EP2919777B1 (en) | 2012-11-13 | 2020-01-08 | Invictus Biotechnology Pty Ltd. | Transmucosal delivery of tocotrienol |
WO2015170286A2 (en) | 2014-05-08 | 2015-11-12 | Biolingus Ip Llc | Modulation of blood glucose levels |
CN104920339B (zh) * | 2015-06-04 | 2017-11-03 | 天津大学 | 利用生物相容性颗粒保存细胞的方法 |
JP6169137B2 (ja) * | 2015-08-07 | 2017-07-26 | バイオリンガス アイピー エルエルシー | 安定化された活性物質含有の生成物の調製方法、および同生成物含有の組成物 |
WO2017075096A1 (en) * | 2015-10-26 | 2017-05-04 | Blaesi Aron H | Solid dosage form immediate drug release and apparatus and method for manufacture thereof |
PE20230382A1 (es) | 2020-05-18 | 2023-03-06 | Orexo Ab | Nueva composicion farmaceutica para administracion de farmacos |
TW202333658A (zh) | 2021-11-25 | 2023-09-01 | 瑞典商奥瑞克索股份公司 | 包含腎上腺素之新穎醫藥組合物 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4949299B1 (pt) * | 1968-09-09 | 1974-12-26 | ||
DK125813B (da) * | 1971-04-16 | 1973-05-07 | Niro Atomizer As | Apparat til tørring af fugtige pulvere. |
DE3690101C2 (de) * | 1985-03-01 | 1995-06-08 | Freunt Ind Co Ltd | Verfahren und Vorrichtung zum Überziehen von fluidisierten Körnern durch Besprühen |
GB2177616B (en) * | 1985-07-09 | 1988-07-06 | Smidth & Co As F L | Gas suspension reactor |
SU1720678A1 (ru) | 1990-05-17 | 1992-03-23 | Рубежанский филиал Днепропетровского химико-технологического института им.Ф.Э.Дзержинского | Массотеплообменный аппарат |
US5601760A (en) * | 1994-09-01 | 1997-02-11 | The Regents Of The University Of California, A California Corporation | Milk derived whey protein-based microencapsulating agents and a method of use |
US6209479B1 (en) * | 1998-12-30 | 2001-04-03 | Aeromatic-Fielder Ag | Apparatus for coating tablets |
AR021347A1 (es) * | 1999-10-20 | 2002-07-17 | Cipla Ltd | Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma |
AUPR272901A0 (en) | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
ES2235642B2 (es) * | 2003-12-18 | 2006-03-01 | Gat Formulation Gmbh | Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos. |
US20060210614A1 (en) * | 2003-12-26 | 2006-09-21 | Nastech Pharmaceutical Company Inc. | Method of treatment of a metabolic disease using intranasal administration of exendin peptide |
GB2418382A (en) * | 2004-09-24 | 2006-03-29 | Mortimer Tech Holdings | Particle treatment in an expanded toroidal bed reactor |
EP2024076A1 (en) * | 2006-05-22 | 2009-02-18 | Nizo Food Research B.V. | Protein encapsulated partocles |
WO2009070011A1 (en) | 2007-11-29 | 2009-06-04 | Nizo Food Research B.V. | Method for making protein-based encapsulates |
WO2009080024A1 (en) * | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising an incretin mimetic |
WO2009080032A1 (en) * | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising a systemically active small peptide |
CN101844053B (zh) * | 2010-05-10 | 2013-06-12 | 重庆佳玛机械制造有限公司 | 一种旋流式流化床包衣机 |
US9795576B2 (en) * | 2010-09-27 | 2017-10-24 | Basf Se | Protective coatings for acidic active ingredients |
RU2563685C2 (ru) * | 2011-02-18 | 2015-09-20 | Сай Ин КО | Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые |
-
2011
- 2011-02-18 RU RU2013140974/13A patent/RU2563685C2/ru active
- 2011-02-18 WO PCT/AU2011/000173 patent/WO2012109694A1/en active Application Filing
- 2011-02-18 JP JP2013553741A patent/JP5793578B2/ja active Active
- 2011-02-18 KR KR1020137021975A patent/KR101796340B1/ko active IP Right Grant
- 2011-02-18 US US13/320,520 patent/US8951566B2/en active Active
- 2011-02-18 AU AU2011323059A patent/AU2011323059B2/en active Active
- 2011-02-18 EP EP11858923.3A patent/EP2675301B1/en active Active
- 2011-02-18 MX MX2013009531A patent/MX359670B/es active IP Right Grant
- 2011-02-18 DK DK11858923.3T patent/DK2675301T3/en active
- 2011-02-18 CN CN201180002271.5A patent/CN102791151B/zh active Active
- 2011-02-18 EP EP18173435.1A patent/EP3381299B1/en active Active
- 2011-02-18 CA CA2827432A patent/CA2827432C/en active Active
- 2011-02-18 MX MX2018007514A patent/MX2018007514A/es unknown
- 2011-02-18 ES ES18173435T patent/ES2832973T3/es active Active
- 2011-02-18 BR BR112013020841A patent/BR112013020841B8/pt active IP Right Grant
-
2014
- 2014-12-30 US US14/586,548 patent/US10369539B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2675301A4 (en) | 2015-07-15 |
KR20140037822A (ko) | 2014-03-27 |
EP2675301B1 (en) | 2018-12-12 |
BR112013020841A2 (pt) | 2016-08-02 |
EP3381299B1 (en) | 2020-08-19 |
KR101796340B1 (ko) | 2017-11-10 |
US20150342886A1 (en) | 2015-12-03 |
RU2563685C2 (ru) | 2015-09-20 |
CN102791151A (zh) | 2012-11-21 |
AU2011323059B2 (en) | 2013-02-21 |
US10369539B2 (en) | 2019-08-06 |
RU2013140974A (ru) | 2015-03-27 |
JP5793578B2 (ja) | 2015-10-14 |
CA2827432A1 (en) | 2012-08-23 |
CN102791151B (zh) | 2016-01-20 |
EP3381299A1 (en) | 2018-10-03 |
DK2675301T3 (en) | 2019-03-25 |
US8951566B2 (en) | 2015-02-10 |
ES2832973T3 (es) | 2021-06-11 |
BR112013020841B1 (pt) | 2021-10-26 |
JP2014508750A (ja) | 2014-04-10 |
WO2012109694A1 (en) | 2012-08-23 |
US20120219624A1 (en) | 2012-08-30 |
CA2827432C (en) | 2020-02-18 |
MX2013009531A (es) | 2014-03-26 |
MX2018007514A (es) | 2022-10-21 |
EP2675301A1 (en) | 2013-12-25 |
MX359670B (es) | 2018-10-05 |
AU2011323059A1 (en) | 2012-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013020841B8 (pt) | Processo para preparar produtos que compreendem ativos estabilizados e composições que compreendem os mesmos | |
AR090465A1 (es) | Formas solidas de un profarmaco de nucleotidos de tiofosforamidato | |
BR112013030163A2 (pt) | composto, uso cosmético de pelo menos um composto, composição farmacêutica ou cosmética e processo para preparar um composto. | |
CR20150326A (es) | Inhibidores de autotaxina | |
BR112015011112A2 (pt) | composto oligomérico, oligômero, composição farmacêutica, uso do composto oligomérico, método de síntese de um composto oligomérico e método de tratamento de uma doença. | |
BRPI1009481A2 (pt) | compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos | |
BR112015009189A2 (pt) | conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo | |
BR112015003397A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente. | |
MD4589B1 (ro) | Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
BRPI1006162A2 (pt) | "composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto". | |
BR112014015294A8 (pt) | método cosmétido; de referência de cor, especialmente para implementar método; sistema para implementar o metodo, pacote de software de computador para implementar o método | |
BR112013030042A2 (pt) | composição em particular composição cosmética, processo para o tratamento cosmético não terapêutico das matérias queratínicas e uso de uma composição. | |
BR112014027544A2 (pt) | composição cosmética, processo cosmético e uso cosmético. | |
BR112013031493A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto. | |
BR112013030318A2 (pt) | composição, processo para o tratamento cosmético não terapêutico das matérias queratínicas e uso de uma composição. | |
BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
BR112012026843A2 (pt) | composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv | |
CL2014003429A1 (es) | Compuestos especificos derivados de indanosulfamida; composicion farmaceutica que los comprende, utiles en el tratamiento e la epilepsia. | |
BR112014026795A2 (pt) | composição cosmética , processo cosmético para tratar a matéria queratínica e uso de uma composição cosmética. | |
EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
EP3034082A4 (en) | Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients | |
NZ731103A (en) | Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto | |
BR112014013354A2 (pt) | processo para a preparação de um polímero, composição, composto, e, formulação | |
BR112015008389A2 (pt) | compostos úteis na síntese de compostos de benzamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: B01J 13/04 (2006.01), A23K 40/30 (2016.01), A23P 1 |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/02/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2651 DE 26/10/2021 QUANTO AO QUADRO REIVINDICATORIO. |